FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to novel derivatives of pyridineamides of the general formula (I): 
wherein one among X or Y means -N= and another means -CR7=; R1, R2, R3, R5, R6 and R7 mean independently hydrogen atom or (C1-C6)-alkyl; R4 means halogen-(C1-C6)-alkyl or unsubstituted phenyl or phenyl substituted with one or some substitutes chosen from group consisting of (C1-C6)-alkyl, halogen atom, halogen-(C1-C6)-alkyl, (C1-C6)-alkoxy-group and cyano-group, and to their pharmaceutically acceptable salts. Indicated compounds possess inhibitory effect with respect to monoaminoxidase B activity and can be used as a medicinal agent in treatment of diseases mediated by monoaminoxidase B inhibitors, in particular, Alzheimer's disease or Parkinson's disease or feeble-mindedness.
EFFECT: valuable medicinal properties of compounds and drug.
12 cl, 1 tbl, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF FLUOROBENZAMIDE AND MEDICINAL AGENT BASED ON THEREOF | 2003 |
|
RU2314289C2 |
| DERIVATIVES OF 4-PYRROLIDINE PHENYL BENZOLE ETHER | 2003 |
|
RU2336268C2 |
| DERIVATIVES OF PYRROLIDONE AS MONOAMINE OXIDASE B (MAO B) AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 2003 |
|
RU2323209C2 |
| PYRROLIDONE DERIVATIVES AS MAO INHIBITORS | 2003 |
|
RU2336267C2 |
| DERIVATIVES OF CINNAMIC ACID AMIDE | 2003 |
|
RU2318802C2 |
| PHTHALIMIDO-DERIVATIVES AS MONOAMINE OXIDASE B INHIBITORS | 2003 |
|
RU2317289C2 |
| 2,3-DIHYDROISOINDOL-1-ONES POSSESSING INHIBITORY EFFECT ON MAO B ACTIVITY | 2003 |
|
RU2322437C2 |
| ACYLATED 6,7,8,9-TETRAHYDRO-5H-BENZOCYCLOHEPTENYLAMINES AND THEIR USING AS PHARMACEUTICAL PREPARATIONS | 2002 |
|
RU2301797C2 |
| 3H-QUINAZOLIN-4-ON DERIVATIVES AND MEDICATION, POSSESSING PROPERTIES OF SPECIFIC MONOAMINOOXIDASE B INHIBITOR | 2003 |
|
RU2340604C2 |
| PYRROLOPYRIDAZINE DERIVATIVES | 2001 |
|
RU2254335C2 |
